The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
- Child Health Institute Science Seminar on February 26th at 1pm
- Rutgers Health and RWJBarnabas Health Receive Grant to Train Health Professionals and Improve Care
- Register Now for Rutgers Health Anniversary Symposium on March 20th
- New NJACTS Publication
- Study Charts Possibilities for a Better Way to Diagnose Gestational Diabetes.